
Rasem Mourad
Examiner (ID: 7274, Phone: (571)270-7770 , Office: P/2836 )
| Most Active Art Unit | 2836 |
| Art Unit(s) | 2836 |
| Total Applications | 617 |
| Issued Applications | 444 |
| Pending Applications | 46 |
| Abandoned Applications | 142 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5421945
[patent_doc_number] => 20090148400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'COMPOSITION OF TUMOUR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/180113
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24835
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148400.pdf
[firstpage_image] =>[orig_patent_app_number] => 12180113
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/180113 | Composition of tumour-associated peptides and related anti-cancer vaccine | Jul 24, 2008 | Issued |
Array
(
[id] => 6343763
[patent_doc_number] => 20100248234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'CANCER DIAGNOSTIC KIT AND CANCER DIAGNOSTIC METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/677755
[patent_app_country] => US
[patent_app_date] => 2008-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8267
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20100248234.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677755
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677755 | Cancer diagnostic kit and cancer diagnostic method | Jul 17, 2008 | Issued |
Array
(
[id] => 7561264
[patent_doc_number] => 20110275097
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-11-10
[patent_title] => 'DRUG SELECTION FOR LUNG CANCER THERAPY USING ANTIBODY-BASED ARRAYS'
[patent_app_type] => utility
[patent_app_number] => 12/172100
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30759
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0275/20110275097.pdf
[firstpage_image] =>[orig_patent_app_number] => 12172100
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/172100 | Drug selection for lung cancer therapy using antibody-based arrays | Jul 10, 2008 | Issued |
Array
(
[id] => 7561264
[patent_doc_number] => 20110275097
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-11-10
[patent_title] => 'DRUG SELECTION FOR LUNG CANCER THERAPY USING ANTIBODY-BASED ARRAYS'
[patent_app_type] => utility
[patent_app_number] => 12/172100
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30759
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0275/20110275097.pdf
[firstpage_image] =>[orig_patent_app_number] => 12172100
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/172100 | Drug selection for lung cancer therapy using antibody-based arrays | Jul 10, 2008 | Issued |
Array
(
[id] => 9551958
[patent_doc_number] => 08759006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia'
[patent_app_type] => utility
[patent_app_number] => 12/169561
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 90
[patent_no_of_words] => 46453
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12169561
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/169561 | PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia | Jul 7, 2008 | Issued |
Array
(
[id] => 5484933
[patent_doc_number] => 20090274698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Combination anti-cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 12/217472
[patent_app_country] => US
[patent_app_date] => 2008-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 77549
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274698.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217472
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217472 | Combination anti-cancer therapy | Jul 2, 2008 | Abandoned |
Array
(
[id] => 6560162
[patent_doc_number] => 20100272635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND/OR PROGNOSIS IN OVARIAN CANCER AND LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/663699
[patent_app_country] => US
[patent_app_date] => 2008-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20753
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272635.pdf
[firstpage_image] =>[orig_patent_app_number] => 12663699
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/663699 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND/OR PROGNOSIS IN OVARIAN CANCER AND LUNG CANCER | Jun 12, 2008 | Abandoned |
Array
(
[id] => 4859013
[patent_doc_number] => 20080267863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/136444
[patent_app_country] => US
[patent_app_date] => 2008-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19864
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267863.pdf
[firstpage_image] =>[orig_patent_app_number] => 12136444
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/136444 | Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer | Jun 9, 2008 | Abandoned |
Array
(
[id] => 5970983
[patent_doc_number] => 20110151580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'METHOD FOR THE DETECTION OF BREAST CANCER BY DETERMINING ALCAM AND/OR BCAM LEVELS IN A PATIENT'
[patent_app_type] => utility
[patent_app_number] => 12/741716
[patent_app_country] => US
[patent_app_date] => 2008-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20525
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20110151580.pdf
[firstpage_image] =>[orig_patent_app_number] => 12741716
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741716 | METHOD FOR THE DETECTION OF BREAST CANCER BY DETERMINING ALCAM AND/OR BCAM LEVELS IN A PATIENT | Jun 5, 2008 | Abandoned |
Array
(
[id] => 5416337
[patent_doc_number] => 20090042224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'METHODS FOR DIAGNOSIS AND/OR PROGNOSIS OF OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/134093
[patent_app_country] => US
[patent_app_date] => 2008-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12978
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042224.pdf
[firstpage_image] =>[orig_patent_app_number] => 12134093
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/134093 | METHODS FOR DIAGNOSIS AND/OR PROGNOSIS OF OVARIAN CANCER | Jun 4, 2008 | Abandoned |
Array
(
[id] => 6343377
[patent_doc_number] => 20100330079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'BIOMARKDER COMBINATIONS FOR COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/451869
[patent_app_country] => US
[patent_app_date] => 2008-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21884
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330079.pdf
[firstpage_image] =>[orig_patent_app_number] => 12451869
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/451869 | Biomarker combinations for colorectal cancer | Jun 3, 2008 | Issued |
Array
(
[id] => 9345211
[patent_doc_number] => 08664359
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-04
[patent_title] => 'Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets'
[patent_app_type] => utility
[patent_app_number] => 12/598746
[patent_app_country] => US
[patent_app_date] => 2008-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 15112
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12598746
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598746 | Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets | Jun 2, 2008 | Issued |
Array
(
[id] => 4760187
[patent_doc_number] => 20080312413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO EPHRIN SIGNALING WITH CUPREDOXINS'
[patent_app_type] => utility
[patent_app_number] => 12/130705
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24287
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312413.pdf
[firstpage_image] =>[orig_patent_app_number] => 12130705
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/130705 | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins | May 29, 2008 | Issued |
Array
(
[id] => 4758887
[patent_doc_number] => 20080311113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'METHOD FOR TREATING ADAMTS-5-ASSOCIATED DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/123990
[patent_app_country] => US
[patent_app_date] => 2008-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 40600
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311113.pdf
[firstpage_image] =>[orig_patent_app_number] => 12123990
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/123990 | METHOD FOR TREATING ADAMTS-5-ASSOCIATED DISEASE | May 19, 2008 | Abandoned |
Array
(
[id] => 6262200
[patent_doc_number] => 20100297067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'METHYLATION MARKERS FOR PROSTATE CANCER AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/600413
[patent_app_country] => US
[patent_app_date] => 2008-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21547
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297067.pdf
[firstpage_image] =>[orig_patent_app_number] => 12600413
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600413 | METHYLATION MARKERS FOR PROSTATE CANCER AND METHODS OF USE | May 13, 2008 | Abandoned |
Array
(
[id] => 5496498
[patent_doc_number] => 20090264526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Natural ligand of G protein coupled receptor RCC356 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/152275
[patent_app_country] => US
[patent_app_date] => 2008-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22873
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264526.pdf
[firstpage_image] =>[orig_patent_app_number] => 12152275
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/152275 | Natural ligand of G protein coupled receptor RCC356 and uses thereof | May 11, 2008 | Issued |
Array
(
[id] => 5337367
[patent_doc_number] => 20090053831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Tyrosine phosphorylation sites'
[patent_app_type] => utility
[patent_app_number] => 12/150903
[patent_app_country] => US
[patent_app_date] => 2008-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 35708
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053831.pdf
[firstpage_image] =>[orig_patent_app_number] => 12150903
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150903 | Tyrosine phosphorylation sites | Apr 29, 2008 | Abandoned |
Array
(
[id] => 5270965
[patent_doc_number] => 20090074741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response'
[patent_app_type] => utility
[patent_app_number] => 12/150164
[patent_app_country] => US
[patent_app_date] => 2008-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10020
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074741.pdf
[firstpage_image] =>[orig_patent_app_number] => 12150164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150164 | Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response | Apr 24, 2008 | Issued |
Array
(
[id] => 5295997
[patent_doc_number] => 20090010923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'TREATMENT OF CANCER WITH ANTI-MUSCARINIC RECEPTOR AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/109156
[patent_app_country] => US
[patent_app_date] => 2008-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17589
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20090010923.pdf
[firstpage_image] =>[orig_patent_app_number] => 12109156
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/109156 | TREATMENT OF CANCER WITH ANTI-MUSCARINIC RECEPTOR AGENTS | Apr 23, 2008 | Abandoned |
Array
(
[id] => 10837501
[patent_doc_number] => 08865173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-21
[patent_title] => 'Treatments for pancreatic cancer metastases'
[patent_app_type] => utility
[patent_app_number] => 12/148922
[patent_app_country] => US
[patent_app_date] => 2008-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 9589
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12148922
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/148922 | Treatments for pancreatic cancer metastases | Apr 22, 2008 | Issued |